Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors
Clinical trial NCT02762981 · COMPLETED
Trial details
- NCT number
- NCT02762981
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-23
- Primary completion
- 2020-05-12
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.